Carolina Breast Cancer Study enrolls record 3,000 participants
Researchers leading the Carolina Breast Cancer Study (CBCS) have enrolled the 3,000th participant for the study's third phase, making it the largest-ever population-based study of breast cancer in North Carolina and one of the largest in the world. This milestone completes enrollment and initiates the five year follow-up.
Launched in 1993, the study aims to improve understanding of breast cancer, including why the disease's fatality rate is higher in African-American women. Phase III will focus specifically on how treatment decisions, access to care, and financial or geographic barriers impact breast cancer outcomes and whether these outcomes are predictable or altered by genetic breast cancer subtypes.
Participants were identified from a list of newly diagnosed breast cancer patients provided by the North Carolina Central Cancer Registry (NCCCR), which identifies and registers all new cancer diagnoses in the state. Participants were then selected through a scientifically sound, randomized process, and physicians were notified of the study's intent to contact their patient.
This recent enrollment milestone puts the total number of CBCS participants at over 7,300.
CBCS is conducted by UNC Gillings School of Global Public Health and UNC School of Medicine faculty with funding from the University Cancer Research Fund, the National Cancer Institute, UNC Breast SPORE and Susan G. Komen for the Cure®.